All sleeping sickness articles
-
NewsAtomic imaging and AI offer new insights into motion of parasite behind sleeping sickness
Researchers applied leading-edge atomic imaging and AI-driven modeling to create the most detailed 3D map yet of the flagellum on Trypanosoma brucei, which causes sleeping sickness.
-
NewsGuinea eliminates human African trypanosomiasis as a public health problem
The World Health Organization (WHO) has congratulated Guinea for eliminating the gambiense form of human African trypanosomiasis as a public health problem. This is the first neglected tropical disease to be eliminated in the country.
-
NewsResearchers reveal breakthrough in the development of drug for sleeping sickness
A novel way to attack the trypanosome parasite through its ribosome prevents the parasite from producing essential proteins, thus impairing its ability to survive.
-
NewsEMA gives positive opinion to first oral treatment of acute form of sleeping sickness
The EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense).
-
NewsLetting go of an extra weight to control sleeping sickness
A new study has found a new strategy by the host to cope with Trypanosoma brucei infection.
-
NewsDevastating pathogen has proteins mapped for the first time
A parasite which has devasting impacts on agriculture and human health is the first pathogen to have its proteins located and mapped within its cells – providing clues to their function and helping to identify potential drug targets.
-
NewsStudy of simple acoziborole regime raises hope for elimination of sleeping sickness in Africa
The Drugs for Neglected Diseases initiative (DNDi) and Sanofi have announced treatment success rates of up to 95% from a Phase II/III study investigating the safety and efficacy of single-dose acoziborole, a potentially transformative investigational treatment for sleeping sickness.